Dr. Janet Chollet

Dr. Janet A. Chollet is a board-certified obstetrician–gynecologist, biotech co-founder, and translational medicine leader based in Boston. She is the Co-Founder and Chief Medical Officer of Procyrn LLC, where she directs programs developing sustained-release hydrogel immune therapeutics and reformulated antivirals. Her work addresses pressing medical needs in maternal–fetal health, neuroinflammation, and HPV-related cervical disease. With more than thirty years of clinical and academic experience, Dr. Chollet has contributed across patient care, teaching, and early-stage biotechnology. She has practiced at leading institutions such as Beth Israel Deaconess Medical Center and the University of Pittsburgh. She has advanced multiple preclinical and early clinical programs alongside her clinical service and holds three U.S. patents in women’s health drug delivery. Her career reflects an ongoing effort to connect frontline medicine with innovation. Dr. Janet Chollet's education began with a Bachelor of Science in Neuroscience from the University of California, Santa Barbara, in 1986. Guided by a strong interest in the relationship between science and health, she earned her Doctor of Medicine degree at New York Medical College in 1991. She completed her residency in Obstetrics and Gynecology at LAC/USC Women’s Hospital, training from 1991 to 1995. These early years shaped her commitment to improving options for women, children, and families. After her residency, she joined Magee-Women’s Hospital, which is affiliated with the University of Pittsburgh, as a staff physician and instructor. Between 2000 and 2007, she combined clinical practice with teaching and mentorship while refining her focus on translational medicine. In 2007, she moved to Boston and joined Beth Israel Deaconess Medical Center, where she continues to practice obstetrics and gynecology. At the same time, she has contributed to academic training, blending her clinical expertise with her interest in translational research.